Successful Therapy of Prolonged Hypotension with an Adrenergic Beta-Receptor Blocking Agent
- 1 April 1964
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 29 (4) , 494-498
- https://doi.org/10.1161/01.cir.29.4.494
Abstract
Two patients with prolonged hypotension requiring continuous vasopressor therapy are described. In both patients treatment with nethalide, a beta-receptor blocking agent, appeared clinically effective in allowing the withdrawal of metaraminol therapy and the maintenance of normotension. The results in these patients tend to fortify a hypothesis of peripheral adrenergic beta-receptor dominance in patients with prolonged hypotension.Keywords
This publication has 11 references indexed in Scilit:
- The Therapy of Cardiogenic ShockAnnals of Internal Medicine, 1963
- Chronic Shock after Myocardial Infarction, Its Mechanisms and ManagementAnnals of Internal Medicine, 1963
- PHARMACOLOGY OF A NEW ADRENERGIC BETA-RECEPTOR-BLOCKING COMPOUND (NETHALIDE)The Lancet, 1962
- Early Potentiation of the Vasoconstrictor Action of Norepinephrine by Guanethidine.Experimental Biology and Medicine, 1962
- Fatal Reaction to Sulfobromophthalein Sodium in a Patient with Bronchial AsthmaPublished by American Medical Association (AMA) ,1961
- Neurogenic HypertensionJAMA, 1960
- A Fatal Reaction to SulfobromophthaleinJAMA, 1960
- BLOCKING OF INHIBITORY ADRENERGIC RECEPTORS BY A DICHLORO ANALOG OF ISOPROTERENOL1958
- Bromsulfalein reactionThe American Journal of Medicine, 1948
- A STUDY OF THE ADRENOTROPIC RECEPTORSAmerican Journal of Physiology-Legacy Content, 1948